(Q37335851)

19 August 2017

1 reference

title

Are declining testosterone levels a major risk factor for ill-health in aging men? (English)

1 reference

19 August 2017

0 references

1 reference

1 reference

B B Yeap

1

1 reference

19 August 2017

publication date

27 November 2008

1 reference

International Journal of Impotence Research

19 August 2017

published in

1 reference

19 August 2017

volume

21

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

24-36

1 reference

Recognizing rare disorders: aromatase deficiency.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Non-classical actions of testosterone: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous sex hormones in men aged 40-80 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Serum androgen levels in black, Hispanic, and white men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone and estradiol among older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

SHBGGene Promoter Polymorphisms in Men Are Associated with Serum Sex Hormone-Binding Globulin, Androgen and Androgen Metabolite Levels, and Hip Bone Mineral Density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

The decline of androgen levels in elderly men and its clinical and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Aging and hormones of the hypothalamo-pituitary axis: gonadotropic axis in men and somatotropic axes in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous sex hormones and cognitive function in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Sex hormones and cognitive function in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

The association between endogenous free testosterone and cognitive performance: a population-based study in 35 to 90 year-old men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Low free testosterone is an independent risk factor for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Free testosterone and risk for Alzheimer disease in older men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Negative association of testosterone on spatial visualization in 35 to 80 year old men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone and cognitive function in ageing men: data from the Florey Adelaide Male Ageing Study (FAMAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

The Effects of Combined Androgen Blockade on Cognitive Function During the First Cycle of Intermittent Androgen Suppression in Patients With Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Associations between serum testosterone fall and cognitive function in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Increasing testosterone levels and effects on cognitive functions in elderly men and women: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone and cognitive function: current clinical evidence of a relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Gonadal dysfunction in systemic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Andropause: is androgen replacement therapy indicated for the aging male?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Andropause: a quality-of-life issue in older males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Quality of life in elderly men with androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Long-term effects of androgen deprivation therapy in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Quality of life in prostate cancer patients taking androgen deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Predictors of skeletal muscle mass in elderly men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous testosterone levels, physical performance, and fall risk in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Association of Testosterone and Estradiol Deficiency with Osteoporosis and Rapid Bone Loss in Older Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Low testosterone levels and the risk of anemia in older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Anemia is associated with disability and decreased physical performance and muscle strength in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone supplementation therapy for older men: potential benefits and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Prevalence of symptomatic androgen deficiency in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

The relationship between libido and testosterone levels in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Comparison of screening questionnaires for the diagnosis of hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Correlations between hormones, physical, and affective parameters in aging urologic outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Epidemiology of erectile dysfunction and its risk factors: a practice-based study in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Prevalence and risk factors for erectile dysfunction in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Male erectile dysfunction and cardiovascular disease: is there an intimate nexus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

The clinical relevance of sex hormone levels and sexual activity in the ageing male

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Relationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Effects of testosterone on sexual function in men: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone supplementation in the aging male: which questions have been answered?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Hormonal supplementation and erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone therapy in erectile dysfunction and hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Erectile dysfunction as a predictor of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous sex hormones and metabolic syndrome in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous hormones and carotid atherosclerosis in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Increased carotid atherosclerosis in andropausal middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous sex hormones and progression of carotid atherosclerosis in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Erectile dysfunction predicts coronary heart disease in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Body composition, metabolic syndrome and testosterone in ageing men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Androgens and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Low serum testosterone and mortality in male veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous sex hormones and cardiovascular disease incidence in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone induces cytoprotection by activating ATP-sensitive K+ channels in the cardiac mitochondrial inner membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone treatment comes of age: new options for hypogonadal men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Risks of testosterone-replacement therapy and recommendations for monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Measurement of testosterone in the diagnosis of hypogonadism in the ageing male

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

A Population-Level Decline in Serum Testosterone Levels in American Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Prevalence of and risk factors for androgen deficiency in middle-aged men in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

Cognitive effects of short-term manipulation of serum sex steroids in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

The role of aromatization in testosterone supplementation: effects on cognition in older men.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Association of specific symptoms and metabolic risks with serum testosterone in older men

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Male erectile dysfunction: its prevalence in Western australia and associated sociodemographic factors.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Androgens and the ageing male

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

High proportions of erectile dysfunction in men with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Erectile dysfunction and subsequent cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III)

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Sex steroids and all-cause and cause-specific mortality in men

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Role of testosterone in older men: recent advances and future directions

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Healthier lifestyle predicts higher circulating testosterone in older men: the Health In Men Study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.60

7 January 2021

Identifiers

DOI

10.1038/IJIR.2008.60

1 reference

19 August 2017

1 reference